A number of genes that are differentially up- or downregulated by p50/RelA- and/or p52/RelB have a high biological significance for HL (for a selection, see Fig. 4c) and encode cytokines and chemokines responsible for clinical symptoms and TF networks implicated in this disease [16]. The gene discussed is NFKB1; the disease is Hodgkins lymphoma.